THE FIRM

Horn & Co. is one of Israel’s prominent boutique firms representing biotechnology, medical device, software and cleantech companies, and founders, academic institutions and leading investors.

Horn & Co. was chosen as the Israeli representative to Biolegis, the European network of leading law firms specializing in biotechnology and medical devices, in which one firm from each country is represented (Biolegis).
READ MORE

PRACTICE AREAS

RECENT NEWS

  • November 2011 Yuval Horn elected as an expert in Life Sciences by Who’s Who of Life Sciences Lawyers 2012 READ MORE
  • October 2011 Vision BI shareholders sell controlling interest to Keyrus, SA READ MORE
  • September 8, 2011 Completion of a merger of IBI Biomedical Innovations Ltd. with Allium Medical Solutions Ltd. READ MORE
  • August 22, 2011 Gefen Biomed Investments Ltd. files Shelf Prospectus with ISA. READ MORE
  • June, 2011 Horn & Co. hires Adv. Moshe Ber as a new addition to its Capital Markets Division.
  • May 22, 2011 Yuval Horn speaks at a dinner party hosted by the Chamber of Commerce Israel – France. READ MORE
  • May 9, 2011 The Israeli chapter by Yuval Horn is being published with the publication of the Anti Corruption 2011 book. READ MORE
  • April 4, 2011 PicApp Inc. sells 100% of the share capital of PicApp Technologies Ltd. to Online Media Solutions Ltd., a wholly owned subsidiary of Ybrant Digital Limited READ MORE
  • March 6, 2011 Gefen Biomed Investments Ltd. enters into a joint venture, Horizon Ventures (A.G.R) Ltd., with Alstom Holdings S.A. and Rotem Industries Ltd., for investment in clean technology enterprises READ MORE
  • February 22, 2011 Yuval Horn publishes a new article: Funding and Opportunities of Life Science Companies – The Israeli Experience READ MORE
  • February 9-11, 2011 Yuval Horn speaks at the IBA Israel Conference: The Globalization of Knowledge Based Industries READ MORE
  • December, 2010 Collplant Holdings Ltd. raises NIS 18.5 from the public on the Tel Aviv Stock Exchange READ MORE
  • November, 2010 Yuval Horn elected as Vice Chairman of the Life Sciences Committee of the International Bar Association READ MORE
  • October 6, 2010 Yuval Horn speaks at the IBA Annual Conference 3-8 October 2010 Vancouver Convention & Exhibition Centre West, Vancouver, Canada READ MORE
  • August, 2010 Protalix Biotherapeutics Inc. approved for listing on the TASE, in addition to its current listing on the NYSE:AMEX. READ MORE
  • June, 2010 Aposense Ltd. raises NIS 64 million in its IPO on TASE, and an additional sum of NIS 30 million in private offerings. READ MORE
  • May, 2011 Yuval Horn Speaks at ISLI BioMed – the 10th National Life Science & Technology Week. READ MORE
3